Cash Flow Fusen Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-93.00
12.00
-11.00
31.00
60.00
67.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
163.00
-118.00
68.00
-36.00
49.00
-69.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
145.00
-44.00
152.00
58.00
175.00
9.00
Cash Flow from Investing Activities
-177.00
-178.00
-15.00
-341.00
-80.00
-298.00
Cash Flow from Financing Activities
17.00
97.00
-60.00
24.00
-130.00
6.00
Net Cash Inflow / Outflow
-14.00
-125.00
78.00
-260.00
-38.00
-276.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
1.00
-1.00
-3.00
6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Fusen Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-93.6216445764116
77.1883373235636
-170.00
-221.29%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
163.178940968438
-22.8183489828874
185.00
815.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
145.019275830332
113.543131932815
32.00
27.72%
Cash Flow from Investing Activities
-177.213134385815
-16.9625521042804
-161.00
-944.73%
Cash Flow from Financing Activities
17.3410761370152
-32.7671361875052
49.00
152.92%
Net Cash Inflow / Outflow
-14.9546994596631
63.8229424176904
-77.00
-123.43%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.101917041195413
0.0094987766617966
0.00
-1172.95%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 427.91% vs -129.02% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
145.02
-44.23
427.91%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
